Uipath (PATH) stock
NYSE
As of the Nov 17, 2026 close (U.S. Eastern)
- Market cap
- $6.46B
- As of Nov 17, 2026
- P/E
- 17.84x
- Trailing twelve months
- P/B
- 3.31x
- Latest reported equity
- P/S
- 3.75x
- Trailing twelve months
- ROE
- 18.6%
- Trailing twelve months
- Dividend yield
- Not available
- Latest fiscal-year dividends
Multiples use the price as of Nov 17, 2026 and may differ from the current price.
- Market cap
- $6.46B
- As of Nov 17, 2026
- P/E
- 17.84x
- Trailing twelve months
- P/B
- 3.31x
- Latest reported equity
- P/S
- 3.75x
- Trailing twelve months
- ROE
- 18.6%
- Trailing twelve months
- Dividend yield
- Not available
- Latest fiscal-year dividends
Multiples use the price as of Nov 17, 2026 and may differ from the current price.
Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.
Price date for the multiples · Nov 17, 2026 · Financial period · Trailing twelve months
P/E and P/S use the latest four quarters where available · P/B uses the latest equity · Computed in-house by ChickenStock
P/E
17.84x
P/B
3.31x
P/S
3.75x
Earnings and dividend metrics▾
Earnings
EPS
—
Earnings per share
BPS
—
Book value per share
ROE
18.6%
Return on equity
- ROE — how much the company earned on shareholder equity over a year: 18.6%.
ⓘ What are these valuation metrics?▾
P/E = share price ÷ earnings per share (EPS)
P/B = share price ÷ book value per share (BPS)
P/S = share price ÷ sales per share
P/E shows how many times annual earnings per share the price is; not all earnings are paid to shareholders. P/B compares the price with net assets, and P/S with sales.
Higher or lower is not good or bad by itself. Typical levels differ by industry; read P/B alongside ROE and P/S alongside margins.
ChickenStock computes these from SEC financial filings: net income and revenue are summed over the latest four quarters, and equity is the latest reported balance.
A negative P/E means a net loss. Reference information only, not a recommendation to buy or sell.
Latest earnings
SEC filingsMay–Jul 2026(FY2027 Q2)
Revenue increased 13.3% from the same period a year earlier.
Key reported figures come first. Select one to see the same quarter across three years.
Revenue · same quarter, three years
Year-ago quarter $362M+13.3%
$316M
May–Jul '24
$362M
May–Jul '25
$410M
May–Jul '26
U.S. Eastern date
ⓘ Notes on these figures▾
- Results for May–Jul 2026 are from the 10-Q submitted to SEC EDGAR on Sep 8, 2026.
- Earnings per share increased from a year earlier. The year-ago value was zero or negative, so no percentage change is shown.
- Revenue increased 13.3% from the same quarter a year earlier.
- Operating income increased from a year earlier. The year-ago value was zero or negative, so no percentage change is shown.
- Net income increased 1,700.0% from the same quarter a year earlier.
- The next earnings report is scheduled for Dec 2, 2026 (U.S. Eastern).
Filed Sep 8, 2026 · 10-Q · SEC EDGAR
Reported results are from SEC EDGAR filings. Reference information only, not investment advice.
Insider transactions
Recent Form 4 filings grouped by person, date and transaction type.
- Brubaker BradChief Legal & Admin Officer · Nov 9, 2026Open-market sale27,404 shares · $357KAvg. price $13.02711,038,703 shares held after
- Malpani RaghavendraCPO & CTO · Oct 22, 2026Open-market sale29,565 shares · $414KAvg. price $14.00181,484,716 shares held after
- Dines DanielCEO and Chairman · Oct 16, 2026Open-market sale1,250,000 shares · $16.3MAvg. price $13.0112
Show 2 price lots
- 1,202,400 shares × $12.9787$15.6M
- 47,600 shares × $13.8325$658K
- Dines DanielCEO and Chairman · Oct 15, 2026Open-market sale1,250,000 shares · $16.8MAvg. price $13.444930,241,238 shares held after
- Brubaker BradChief Legal & Admin Officer · Oct 12, 2026Open-market sale27,404 shares · $374KAvg. price $13.63141,066,107 shares held after
- Malpani RaghavendraCPO & CTO · Oct 9, 2026Open-market sale29,564 shares · $399KAvg. price $13.50511,514,281 shares held after
- Gupta AshimCOO · Oct 2, 2026Open-market sale66,052 shares · $870KAvg. price $13.1681,902,434 shares held after
- Gupta AshimCOO · Oct 1, 2026Shares withheld for taxes68,891 shares · $885KAvg. price $12.84
Show 2 price lots
- 56,625 shares × $12.84$727K
- 12,266 shares × $12.84$157K
- Malpani RaghavendraCPO & CTO · Oct 1, 2026Shares withheld for taxes38,368 shares · $493KAvg. price $12.84
Show 2 price lots
- 36,273 shares × $12.84$466K
- 2,095 shares × $12.84$27K
- Ramani HiteshChief Financial Officer · Oct 1, 2026Shares withheld for taxes30,620 shares · $393KAvg. price $12.84
Show 2 price lots
- 29,297 shares × $12.84$376K
- 1,323 shares × $12.84$17K
- Brubaker BradChief Legal & Admin Officer · Oct 1, 2026Shares withheld for taxes35,395 shares · $454KAvg. price $12.84
Show 2 price lots
- 29,184 shares × $12.84$375K
- 6,211 shares × $12.84$80K
- Malpani RaghavendraCPO & CTO · Sep 17, 2026Open-market sale40,464 shares · $567KAvg. price $14.00141,582,213 shares held after
- Malpani RaghavendraCPO & CTO · Sep 16, 2026Open-market sale98,429 shares · $1.4MAvg. price $13.81351,622,677 shares held after
- Gupta AshimCOO · Sep 11, 2026Open-market sale117,339 shares · $1.6MAvg. price $13.85392,037,377 shares held after
- Dines DanielCEO and Chairman · Sep 8, 2026Conversion5,000,000 shares · $0Avg. price $05,000,000 shares held after
- Dines DanielCEO and Chairman · Sep 8, 2026Other10,000,000 shares · $0Avg. price $0
Show 2 price lots
- 5,000,000 shares × $0$0
- 5,000,000 shares × $0$0
- Bagli Yazdi FramrozDirector · Sep 3, 2026Grant or award34,582 shares · $0Avg. price $034,582 shares held after
- Malpani RaghavendraCPO & CTO · Sep 3, 2026Grant or award1,125,000 shares · $0Avg. price $01,721,106 shares held after
- Gupta AshimCOO · Sep 3, 2026Grant or award1,125,000 shares · $0Avg. price $02,154,716 shares held after
- Brubaker BradChief Legal & Admin Officer · Sep 3, 2026Grant or award300,000 shares · $0Avg. price $01,128,906 shares held after
- Ramani HiteshChief Financial Officer · Sep 3, 2026Grant or award655,368 shares · $0Avg. price $0
Show 2 price lots
- 525,000 shares × $0$0
- 130,368 shares × $0$0
- Dines DanielCEO and Chairman · Aug 19, 2026Open-market sale1,402,347 shares · $22.5MAvg. price $16.072626,491,238 shares held after
- Ramani HiteshChief Accounting Officer · Aug 14, 2026Open-market sale25,000 shares · $419KAvg. price $16.75235,052 shares held after
- Ramani HiteshChief Accounting Officer · Aug 13, 2026Open-market sale25,000 shares · $413KAvg. price $16.5260,052 shares held after
Only transactions reported on SEC Form 4 are shown. A sale may follow a pre-arranged 10b5-1 plan, and items such as option exercises or shares withheld for taxes are not open-market trades.
Recent SEC filings
40 filingsFilings submitted to the U.S. Securities and Exchange Commission (EDGAR). Dates are SEC filing dates (U.S. Eastern). Form and item names are the official SEC titles. The Earnings and Risk tags come directly from form types and item codes; they are not written by AI. Insider ownership reports (Forms 3, 4 and 5) are excluded.
Company overview
Expand ▾
Uipath (PATH) stock information
NYSE
Uipath (PATH) is listed on NYSE. Its market capitalization is about $6.5B. On trailing-twelve-month earnings the P/E ratio is 17.84, and the P/B ratio is 3.31. Return on equity is 18.6%. These figures are computed in-house from official filings and are reference information only.
Uipath — frequently asked questions
- What is the P/E ratio of Uipath (PATH)?
- On a trailing-twelve-month basis, PATH trades at a P/E ratio of 17.84. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
- What is the market capitalization of Uipath?
- PATH has a market capitalization of about $6.5B. The figure moves with the share price and is refreshed each trading day.
- Is this page investment advice?
- No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.
All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.